PFE is in a strong uptrend
+81
BearishSidewaysBullish
Why this reading
- Price is above its 50-day average ($28.49).
- Price is above its 200-day average ($26.30).
- The 50-day average is rising (+0.23%/day).
- 50-day average is above the 200-day (long-term structure is up).
- MACD momentum is improving and the MACD line is above zero.
- Recent swing highs and lows are mixed (consolidation).
Price chart
Lower pane: RSI (14) with 70 and 30 marked. Arrows mark candlestick patterns.
Indicators
| Indicator | Value | Reading | What it means |
|---|---|---|---|
| Moving averages | Bullish stack | Bullish | 20-day $29.03, 50-day $28.49, 200-day $26.30 |
| RSI (14) | 60.4 | Bullish | Buyers have the upper hand. |
| MACD (12,26,9) | +0.01 | Bullish | MACD is above its signal line. |
| Bollinger %B | 0.70 | Neutral | Bands are 12.7% wide. |
| Volatility (ATR 14) | $0.55 (1.8%) | Neutral | Typical daily volatility. |
| Volume vs 20d avg | 0.30× | Neutral | Light volume — the latest move has little participation. |
| 52-week range | 92% | Bullish | Low $22.57, high $30.44 |
Key levels
- $32.96Resistance, 5 touches+10.6%
- $30.77Resistance, 4 touches+3.3%
- $30.23Resistance, 3 touches+1.4%
- $29.80Last close
- $28.81Support, 4 touches-3.3%
- $27.72Support, 5 touches-7.0%
- $27.14Support, 4 touches-8.9%
Recent candlestick patterns
- DojiNeutral
Open and close nearly equal — indecision between buyers and sellers.
- DojiNeutral
Open and close nearly equal — indecision between buyers and sellers.
- DojiNeutral
Open and close nearly equal — indecision between buyers and sellers.
Latest news
- Pfizer Reports Reduction in Payments to Swiss Healthcare Professionalsfiscal.ai
- Pfizer Announces Corporate Restructuring and Clinical Trial Adjustmentsfiscal.ai
- Pfizer Divests Stake in ViiV Healthcarefiscal.ai
- Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma Patientsbenzinga
- Pfizer Announces Positive Topline Results from Phase 3 MagnetisMM-32 Study of ELREXFIOfiscal.ai